#Canada Contrast and Imaging Agents in Interventional X-ray Market Key Players
Explore tagged Tumblr posts
Text
Landscape of the Canada Contrast and Imaging Agents in the Interventional X-Ray Market Outlook: Ken Research
Landscape of the Canada Contrast and Imaging Agents in the Interventional X-Ray Market Outlook: Ken Research
Buy Now
According to the report analysis, ‘Canada Contrast and Imaging Agents in Interventional X-ray Market Industry Trends and Forecast to 2026’ states that the Canada contrast and imaging agents in Interventional X-ray Market is predicted to account a healthy a CAGR of 4.9% in the forecast period of 2019 to 2026. Whereas, contrast agents which are also known as contrast material or contrast…
View On WordPress
#BRACCO Canada Contrast and Imaging Agents in Interventional X-ray#Canada Contrast and Imaging Agents in Interventional X-ray Analysis#Canada Contrast and Imaging Agents in Interventional X-ray Challenges#Canada Contrast and Imaging Agents in Interventional X-ray Clinics#Canada Contrast and Imaging Agents in Interventional X-ray Congenital Heart Disease#Canada Contrast and Imaging Agents in Interventional X-ray Hospital#Canada Contrast and Imaging Agents in Interventional X-ray Industry#Canada Contrast and Imaging Agents in Interventional X-ray Industry Research#Canada Contrast and Imaging Agents in Interventional X-ray Industry Research Report#Canada Contrast and Imaging Agents in Interventional X-ray Market#Canada Contrast and Imaging Agents in Interventional X-ray Market Application#Canada Contrast and Imaging Agents in Interventional X-ray Market Forecast#Canada Contrast and Imaging Agents in Interventional X-ray Market Future Outlook#Canada Contrast and Imaging Agents in Interventional X-ray Market Growth#Canada Contrast and Imaging Agents in Interventional X-ray Market Key Players#Canada Contrast and Imaging Agents in Interventional X-ray Market Overview#Canada Contrast and Imaging Agents in Interventional X-ray Market Research#Canada Contrast and Imaging Agents in Interventional X-ray Market Research Report#Canada Contrast and Imaging Agents in Interventional X-ray Market Revenue#Canada Contrast and Imaging Agents in Interventional X-ray Market Scope#Canada Contrast and Imaging Agents in Interventional X-ray Market Segmentation#Canada Contrast and Imaging Agents in Interventional X-ray Market Share#Canada Contrast and Imaging Agents in Interventional X-ray Market Size#Canada Contrast and Imaging Agents in Interventional X-ray Market Trends#Canada Contrast and Imaging Agents in Interventional X-ray Market Value#Canada Contrast and Imaging Agents in Interventional X-ray Opportunities#Canada Contrast and Imaging Agents in Interventional X-ray Private Hospitals#Canada Contrast and Imaging Agents in Interventional X-ray Structural Heart Diseas#Contrast and Imaging Agents in Interventional X-ray#FUJIFILM VisualSonics Inc. Canada Contrast and Imaging Agents in Interventional X-ray
0 notes
Text
Global Medical Imaging Market – Industry Trends and Forecast to 2027
Global Medical Imaging Market By Type (Services, Product), Modality (Stationary, Portable), Procedure (Computed Tomography (CT) Scan, X-Ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Imaging (SPECT/PET), Others), Technology (Direct Digital Radiology, Computed Radiology), Patient Age (Adults, Pediatric), Application (Cardiology, Pelvic And Abdominal, Oncology, Mammography, Gynecology, Neurology, Urology, Musculoskeletal, Dental, Others), End Users (Hospitals, Diagnostic Centers, Imaging Centers, Specialty Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa), Market Trends and Forecast to 2027.
Global Medical Imaging Market report helps out to meet the strategic and specific needs of the organization or business, by providing comprehensive market research analysis. This market research report delivers an analytical measurement of the main challenges faced by the business currently and in the upcoming years. It is a wide-ranging market research report that comprises of various parameters of the market namely market definition, currency and pricing, market segmentation, market overview, premium insights, key insights and company profile of the key market players. Each of these factors is again researched intensely for the enhanced and actionable market insights. Market study of Global Medical Imaging Market report considers a market attractiveness analysis, where each segment is benchmarked based on its market size, growth rate, and general attractiveness. This research report helps to understand the various drivers and restraints impacting the market during the forecast period. The report has been formed by using information from trustworthy sources such as journals, websites, and annual reports of the companies, white papers, and mergers. All of this collected data is then checked and validated by the market experts for the readers and end users. The Global Medical Imaging Market report has appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Market Analysis and Insights: Global Medical Imaging Market
Medical imaging market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2020 to 2027and expected to reach USD 265,334.23 million by 2027 from USD 120,237.71 million in 2019. Rising minimally invasive diagnostic and therapeutic interventional procedures and increasing prevalence of chronic diseases are the factors for the market growth.
Get Sample Report + All Related Graphs & Charts @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-imaging-market
The major players covered in the report are Spectrum Health, RamSoft, Inc., InHealth Group, Radiology Reports online, Siemens Healthineers AG, Sonic Healthcare, RadNet, Inc., GE Healthcare (A subsidiary of GENERAL ELECTRIC), Alliance HealthCare Services, Koninklijke Philips N.V., Hologic Inc., Shimadzu Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., CANON MEDICAL SYSTEMS CORPORATION, Carl Zeiss Ag, FUJIFILM Corporation, Hitachi, Ltd., MEDNAX Services, Inc., Carestream Health (A subsidiary of Onex Corporation), Teleradiology Solutions, UNILABS, ONRAD, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Medical imaging can be thought of as a technique to create various internal images of the body for diagnosis and treatment of the disease. This technique is mainly useful in improving the health of people around the world, as it can help in the early diagnosis of some internal diseases and providing the right treatment for a particular disease. May also examine what has already been diagnosed with treatment.
The technology of medical imaging is used at the numerous levels of patient management process, such as screening, diagnosis, therapy delivery, staging, and medical follow-up.. For instance, According to the National Health Council, in America, approximately 133 million people were affected by the chronic diseases in 2019 and it is estimated that in 2020, this number will grow up to 157 million with 81 million people having multiple conditions. Increasing technology advancements will also drive the market.
This medical imaging market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Grab Your Report at an Impressive 30% Discount! Please click Here @
https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-imaging-market
Global Medical Imaging Market Scope and Market Size
Global medical imaging market is segmented of the basis of type, modality, procedure, technology, patient age, application, end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Medical Imaging Market Country Level Analysis
Global medical imaging market is analysed and market size information is provided by country, type, modality, procedure, technology, patient age, application, end users as referenced above.
The countries covered in the medical imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America.
North America dominates the medical imaging market as the U.S. is leader in medical imaging. Due to better advancement in products and services in North America, the region dominates medical imaging. North America spends high amount on health care; particularly U.S. Asia-Pacific is growing with the highest CAGR due to the increasing medical tourism and increasing population. The number of companies in emerging countries is increasing due to increasing demand for diagnostics in clinics, hospitals and other sectors. Additionally, the increasing number of healthcare expenditure and increasing number of hospitals and clinical diagnostic laboratories in China and India upsurge demand of medical imaging. The Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2020 to 2027 because of increasing infectious diseases. Germany dominates the European market due to the technological advanced health system in the country. In the Asia-Pacific region, Japan dominates due to the technological advancements healthcare industry and increasing purchasing power in this country.
Download Free TOC @
https://www.databridgemarketresearch.com/toc/?dbmr=global-medical-imaging-market
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
How will the report help new companies to plan their investments in the Medical Imaging market?
The Medical Imaging market research report classifies the competitive spectrum of this industry in elaborate detail.
The report also mentions about the details such as the overall remuneration, product sales figures, pricing trends, gross margins, etc.
Information about the sales & distribution area alongside the details of the company, such as company overview, buyer portfolio, product specifications, etc., are provided in the study.
Increasing Cases of Chronic Diseases and New Technology Penetration
Global medical imaging market also provides you with detailed market analysis for every country growth in medical device industry with medical imaging sales, impact of technological development in contrast agents and changes in regulatory scenarios with their support for the medical imaging market.
Competitive Landscape and Medical Imaging Market Share Analysis
Global medical imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global medical imaging market.
Many joint ventures and developments are also initiated by the companies worldwide which are also accelerating the growth of global medical imaging market.
For instance,
In December 2019, GE Healthcare (General Electric Company) and Affidea (a pan-European leader in advanced clinical imaging) has signed an agreement to develop digital technologies and imaging in the Affidea network. The agreement contains 40 CT scanners, 60 new MRIs, 30 X-ray machines and 50 ultrasound equipment over the next 3 years. This agreement helped the company to increase its credibility in the market.
In May 2019, Carstream Health has launched new software, ImageView software. This software helps in the digital revolution in its mobile X-ray system with advanced features of Microsoft Window 10 which eases the collection of detector performance data. This new software helps the company to offer accurate information to the patient.
Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for medical imaging through technological advancements.
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
0 notes
Text
Contrast Media Market Research Report, Share, and Forecast to 2025
“The Contrast Media Market is expected to burgeon with a prominent growth rate over the forecast years to reach about US$ 6,428.5 Mn by 2025 owing to surge in prevalence of cancer, cardiovascular disorders, and other chronic diseases across the globe.”
Precision Business Insights (PBI) in its report titled “Contrast Media Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
The contrast media market size was valued at US$ XX in 2018 and expected to reach US$ 6,428.5 Mn by 2025. Surge in the incidence of certain types of cancers such as prostate cancer, brain cancer, and breast cancer due to lifestyle changes coupled with increase in the demand for early stage diseases diagnosis are major factors boost the market over the forecast years. For instance, as per World Health Organization 2018 data, approximately 9.6 Mn deaths happened due to the cancer around the globe. Moreover, increase in R&D activities for the launch of newer contrast media agents, grow in demand for advanced diagnostic imaging techniques such as CT-scan and MRI, and favorable reimbursement policies for diagnostic procedures in developed and developing countries driving the contrast media agents market. However, high cost for the diagnostic procedures, poor healthcare infrastructure in underdeveloped countries, and side effects such as allergic reactions with the administration of contrast media are anticipated to limit the growth of global contrast media market in the near future.
Contrast media market segmented on the basis of product type, modality, route of administration, disease indication, application, end user, and region.
Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=17188
Iodinated Contrast Media Expected to Dominate the Market
Based on product type, global contrast media market segmented into Gadolinium-based contrast media, Iodinated contrast media, Barium-based contrast media, and Microbubble contrast media. Among all the products, iodinated contrast media dominated the market in 2018 and the segment is expected to hold the largest share over 2019-2025 owing to high penetration of iodinated contrast media in CT scans and X-ray procedures coupled with surge in R&D for the development and launch of newer products into market. For instance, in July 208, GE Healthcare launched Omnipaque Oral Solution, a ready-to-drink iodinated contrast medium used for CT Scan of the abdominal gastrointestinal tract in adults and children. However, a moderate growth rate observed in gadolinium-based contrast media owing stringent regulations for the use of these products in Europe.
North America Accounts for Major Revenue Share for Contrast Media Market
Precision Business Insights (PBI), contrast media market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among all the regions, North America dominated the market in 2018 due to increased rates of certain types of cancers in U.S. and Canada. For instance, according to National Cancer Institute 208, approximately 1,735,350 cases diagnosed with cancer in U.S. Moreover, rise in R&D for the development of newer products, well-established healthcare infrastructure, and favorable reimbursement policies are expected to boost the contrast media market in the North America region. Europe contrast media market anticipated to burgeon at prominent growth rate owing to adoption of advanced diagnostic procedures, increase in healthcare expenditure, and surge in incidence of cancer and other chronic diseases in the region.
Product Approval and Launch of Advanced Technologies in Contrast Media Market
In November 2019, GE Healthcare received FDA approval for Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent used with MRI in brain, spine and associated tissues in adult and pediatric patients for better visualization of blood brain barrier (BBB) and/or abnormal vascularity.
Key player’s profiles in the report are o GE Healthcare, Bracco Imaging, Bayer HealthCare, Guerbet, Lantheus, Daiichi Sankyo, Unijules Life Sciences, J.B. Chemicals and Pharmaceuticals, Spago Nanomedicine, Taejoon Pharm, Jodas, and Magnus Health.
Detailed Segmentation
By Product Type
o Barium-based Contrast Media
o Iodinated Contrast Media
o Gadolinium-based Contrast Media
o Microbubble Contrast Media
By Modality
o X-Ray
o CT-Scan
o Magnetic Resonance Imaging (MRI)
o Ultrasound
o Others
By Route of Administration
o Oral Contrast Media
o Injectable Contrast Media
o Rectal Contrast Media
o Urethral Contrast Media
o Others
By Disease Indication
o Musculoskeletal Disorders
o Neurological Disorders
o Nephrological Disorders
o Cardiovascular Disorders
o Oncology
o Gastrointestinal Disorders
By Application
o Radiology
o Interventional Radiology
o Interventional Cardiology
By End User
o Hospitals
o Clinics
o Diagnostic Centers
o Others
Geography
o North America
· US
· Canada
o Europe
· Germany
· France
· UK
· Italy
· Spain
· Russia
· Poland
· Rest of Europe
o Asia-Pacific
· Japan
· China
· India
· Australia & New Zealand
· ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
· South Korea
· Rest of Asia-Pacific
o Latin America
· Brazil
· Mexico
· Argentina
· Rest of Latin America
o Middle East and Africa (MEA)
· Gulf Cooperation Council (GCC) Countries
· Israel
· South Africa
· Rest of MEA
For more information: https://www.precisionbusinessinsights.com/market-reports/global-contrast-media-market/
About Us:
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Contact Us:
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
0 notes
Text
Discography Market Growth Analysis, Industry Trends, and Forecast by 2023
As per Market Research Future (MRFR)’s Analysis, the Global Discography Market is projected to expand at a healthy pace in the foreseeable future.
Global Discography Market is expected to grow at an approximate CAGR of 8.20% during the forecast period. Discography or discogram, is an interventional diagnostic imaging test that uses X-rays to examine the intervertebral discs of the spines. During the discographic procedures, a special gadolinium and iodine dye is injected into the injured disc which makes the disc visible on a fluoroscope monitor and X-ray film. Increasing prevalence of degenerative disc disease and growing geriatric population are estimated to be the major drivers for market growth during the forecast period.
Access Free Sample Copy at https://www.marketresearchfuture.com/sample_request/5364 .
According to a study published in the Asian Spine Journal in 2016, it is estimated that lumbar back pain affects 70% to 85% of the individuals in their life. Further, the study states that the prevalence of back pain increases with age and the recurrence is estimated to be as high as 85%. Moreover, according to the World Health Organization, the world’s geriatric population is expected to reach 2 billion by 2050 from 900 million in 2015. Additionally, about 80% of the total geriatric population is estimated to live in the low and middle income countries. Factors such as increasing per capita healthcare expenditure and rising investments by the key market players in research and development processes will fuel the market growth during the forecast period. However, high procedural cost followed by the complications in the operations, lack of awareness and low per capita healthcare expenditure in the developing countries is projected to restrain the market growth during the forecast period. The cost for discography procedures is estimated to be around USD 1,500, making it an out-of-pocket investment for a majority of the patients.
Major Players are:
Stryker (U.S.)
Johnson & Johnson Services
Inc. (U.S.)
Merit Medical Systems,
Inc. (U.S.), Medtronic (U.S.)
GFS Chemicals
Etc.
The leading market players in the Asthma and COPD Drug focus to expand their business operations in the emerging countries. The companies operating in the market have consistently introduced innovative solutions to enhance their product portfolio. Product approval and clinical trial are observed as the two prominent growth strategies adopted by the key market players.
Segmentation:
The global discography market is segmented on the basis of type, component, application, and indication and end user. On the basis of the type, the market is segmented into lumbar discography, cervical discography, thoracic discography, and others. On the basis of the component, the market is categorised into contrast agent, imaging and others. The contrast agent segment is sub-segmented into iodine, gadolinium, and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others. On the basis of the application, the market is segmented into herniated discs, scoliosis, burst fracture, and others. On the basis of the indication, the market is segmented into spinal decompression, lumbar surgery, laminectomy, and others. On the basis of the end user, the market is segmented into hospitals, retail pharmacies, academic institutes, others.
Get Full Report at https://www.marketresearchfuture.com/reports/discography-market-5364
Regional Analysis:
The Americas dominates the global discography market owing to a well-developed healthcare sector. Increasing prevalence of lower back pain, rising healthcare expenditure have boosted the growth of the market in Americas. Moreover, the presence of developed economies like U.S. and Canada within the regional boundaries fuels the market growth.
Europe is the second large market for discography, which is followed by Asia Pacific. Availability of funds for research, well developed healthcare infrastructure, huge patient population and government support for research & development will drive the market in the Europe.
Followed by Europe, Asia Pacific is estimated to be the fastest growing region for the market. Presence of developing economies like India and China within the region boost the market growth within the region. Additionally, the presence of favourable government policies and huge opportunities for the untapped market within the region fuels the market growth. According to the Indian Brand Equity Foundation in 2017, Indian healthcare sector was estimated to grow with a fast pace and reach USD 280 billion by 2020.
The Middle East & Africa has the least share in the global discography market due to presence of poor economies especially in the African region. Majority of the market of the Middle & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the economies like Saudi Arabia, Kuwait, and Qatar within the region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
0 notes
Text
Diagnostic Imaging Agents Market Research Report: Forecast up to 2025
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.
Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.
View Report-
http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Global Medical Imaging Market – Industry Trends and Forecast to 2027
Global Medical Imaging Market By Type (Services, Product), Modality (Stationary, Portable), Procedure (Computed Tomography (CT) Scan, X-Ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Imaging (SPECT/PET), Others), Technology (Direct Digital Radiology, Computed Radiology), Patient Age (Adults, Pediatric), Application (Cardiology, Pelvic And Abdominal, Oncology, Mammography, Gynecology, Neurology, Urology, Musculoskeletal, Dental, Others), End Users (Hospitals, Diagnostic Centers, Imaging Centers, Specialty Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa), Market Trends and Forecast to 2027.
Global Medical Imaging Market report helps out to meet the strategic and specific needs of the organization or business, by providing comprehensive market research analysis. This market research report delivers an analytical measurement of the main challenges faced by the business currently and in the upcoming years. It is a wide-ranging market research report that comprises of various parameters of the market namely market definition, currency and pricing, market segmentation, market overview, premium insights, key insights and company profile of the key market players. Each of these factors is again researched intensely for the enhanced and actionable market insights. Market study of Global Medical Imaging Market report considers a market attractiveness analysis, where each segment is benchmarked based on its market size, growth rate, and general attractiveness. This research report helps to understand the various drivers and restraints impacting the market during the forecast period. The report has been formed by using information from trustworthy sources such as journals, websites, and annual reports of the companies, white papers, and mergers. All of this collected data is then checked and validated by the market experts for the readers and end users. The Global Medical Imaging Market report has appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Market Analysis and Insights: Global Medical Imaging Market
Medical imaging market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2020 to 2027and expected to reach USD 265,334.23 million by 2027 from USD 120,237.71 million in 2019. Rising minimally invasive diagnostic and therapeutic interventional procedures and increasing prevalence of chronic diseases are the factors for the market growth.
Get Sample Report + All Related Graphs & Charts @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-imaging-market
The major players covered in the report are Spectrum Health, RamSoft, Inc., InHealth Group, Radiology Reports online, Siemens Healthineers AG, Sonic Healthcare, RadNet, Inc., GE Healthcare (A subsidiary of GENERAL ELECTRIC), Alliance HealthCare Services, Koninklijke Philips N.V., Hologic Inc., Shimadzu Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., CANON MEDICAL SYSTEMS CORPORATION, Carl Zeiss Ag, FUJIFILM Corporation, Hitachi, Ltd., MEDNAX Services, Inc., Carestream Health (A subsidiary of Onex Corporation), Teleradiology Solutions, UNILABS, ONRAD, Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Medical imaging can be thought of as a technique to create various internal images of the body for diagnosis and treatment of the disease. This technique is mainly useful in improving the health of people around the world, as it can help in the early diagnosis of some internal diseases and providing the right treatment for a particular disease. May also examine what has already been diagnosed with treatment.
The technology of medical imaging is used at the numerous levels of patient management process, such as screening, diagnosis, therapy delivery, staging, and medical follow-up.. For instance, According to the National Health Council, in America, approximately 133 million people were affected by the chronic diseases in 2019 and it is estimated that in 2020, this number will grow up to 157 million with 81 million people having multiple conditions. Increasing technology advancements will also drive the market.
This medical imaging market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Grab Your Report at an Impressive 30% Discount! Please click Here @
https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-medical-imaging-market
Global Medical Imaging Market Scope and Market Size
Global medical imaging market is segmented of the basis of type, modality, procedure, technology, patient age, application, end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Medical Imaging Market Country Level Analysis
Global medical imaging market is analysed and market size information is provided by country, type, modality, procedure, technology, patient age, application, end users as referenced above.
The countries covered in the medical imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, South Africa, Rest of Middle East and Africa as a part of Middle East and Africa, Brazil, Argentina and Rest of South America as part of South America.
North America dominates the medical imaging market as the U.S. is leader in medical imaging. Due to better advancement in products and services in North America, the region dominates medical imaging. North America spends high amount on health care; particularly U.S. Asia-Pacific is growing with the highest CAGR due to the increasing medical tourism and increasing population. The number of companies in emerging countries is increasing due to increasing demand for diagnostics in clinics, hospitals and other sectors. Additionally, the increasing number of healthcare expenditure and increasing number of hospitals and clinical diagnostic laboratories in China and India upsurge demand of medical imaging. The Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2020 to 2027 because of increasing infectious diseases. Germany dominates the European market due to the technological advanced health system in the country. In the Asia-Pacific region, Japan dominates due to the technological advancements healthcare industry and increasing purchasing power in this country.
Download Free TOC @
https://www.databridgemarketresearch.com/toc/?dbmr=global-medical-imaging-market
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
How will the report help new companies to plan their investments in the Medical Imaging market?
The Medical Imaging market research report classifies the competitive spectrum of this industry in elaborate detail.
The report also mentions about the details such as the overall remuneration, product sales figures, pricing trends, gross margins, etc.
Information about the sales & distribution area alongside the details of the company, such as company overview, buyer portfolio, product specifications, etc., are provided in the study.
Increasing Cases of Chronic Diseases and New Technology Penetration
Global medical imaging market also provides you with detailed market analysis for every country growth in medical device industry with medical imaging sales, impact of technological development in contrast agents and changes in regulatory scenarios with their support for the medical imaging market.
Competitive Landscape and Medical Imaging Market Share Analysis
Global medical imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global medical imaging market.
Many joint ventures and developments are also initiated by the companies worldwide which are also accelerating the growth of global medical imaging market.
For instance,
In December 2019, GE Healthcare (General Electric Company) and Affidea (a pan-European leader in advanced clinical imaging) has signed an agreement to develop digital technologies and imaging in the Affidea network. The agreement contains 40 CT scanners, 60 new MRIs, 30 X-ray machines and 50 ultrasound equipment over the next 3 years. This agreement helped the company to increase its credibility in the market.
In May 2019, Carstream Health has launched new software, ImageView software. This software helps in the digital revolution in its mobile X-ray system with advanced features of Microsoft Window 10 which eases the collection of detector performance data. This new software helps the company to offer accurate information to the patient.
Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for medical imaging through technological advancements.
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
0 notes
Text
Diagnostic Imaging Agents Market Research Report Details: Emerging Economies Responsible To Drive Future Demand Across the World
The Diagnostic Imaging Agents Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions.
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
Get accurate market forecast and analysis on the Diagnostic Imaging Agents Market. Request a sample to stay abreast on the key trends impacting this market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally.
Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents.
The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
Browse more detail information about diagnostic imaging agents market:
http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com/
0 notes
Text
Diagnostic Imaging Agents Market Research Report: Forecast up to 2025
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.
Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.
View Report-
http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Diagnostic Imaging Agents Market Research Report: Forecast up to 2025
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.
Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.
View Report-
http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Diagnostic Imaging Agents Market Research Report: Forecast up to 2025
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.
Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.
View Report-
http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Contrast Media/Contrast Agent Market: Key Players Profile And Market Analysis 2016 – 2024
Contrast medium or contrast agent is a substance used in medical imaging to enhance the contrast of fluids or structures inside the body. These help in better imaging of anatomical structures and organs by increasing the image contrast. Hence, these are helpful in diagnostic methods such as CT scan and in some critical surgeries. The global contrast media or contrast agent market is a fairly mature, and is expected to witness strong growth driven by increasing imaging diagnosis and surgical procedures. The contrast media or contrast agent market has evolved significantly over the last century. Initially, radiologists and practitioners used barium and iodine-based agents. Advancement in nanotechnology has enabled usage of gold nanoparticle along with radiopharmaceuticals.
Get Sample Copy of this Report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=876
Growth of the contrast media or contrast agent market is driven by increasing demand for image guided diagnostics and procedures, rising mortality of chronic diseases such as cancer, gastrointestinal disorders, and cardiac diseases, and growing demand for image guided surgical procedures. Growth of the market can also be attributed to factors such as increasing approvals for contrast agents and rising number of private and government diagnostic centers for improving diagnostic imaging services. Moreover, increasing research studies about applications of various contrast agents and strong pipeline products of the companies are projected to create new opportunities in the global contrast media or agent market.
Advancement in technology and use of advanced techniques such as gas micro bubble technology in MRI imaging are likely to contribute to the growth of the market. Global reforms regarding better healthcare and radiopharmaceuticals, and increasing investments in the contrast media market are fueling market growth. However, sluggish economies, effecting sales of contrast media in medical reform, and fluctuating economies of regions like Europe may hamper the growth of the market.
The contrast media or contrast agent market can be segmented based on product, procedure, application, route of administration, indication, and region. The market can be segmented into barium-based contrast media, gadolinium-based contrast media, and iodinated contrast media. The iodinated contrast media segment accounts for the major market share due to high usage of iodinated agents in CT scan. Based on product type, the contrast media or agent market can be segmented into magnetic resonance imaging, ultrasound, X-ray/computed tomography (CT), and catheterization laboratory. In terms of application, the market can be categorized into interventional cardiology, radiology, and interventional radiology. Based on route of administration, the market can be segmented into injectable contrast media, oral contrast media, urethral contrast media, and rectal contrast media. The injectable contrast media segment accounted for the major share of the market due to increasing number of CT scans and MRIs performed. In terms of indication, the market has been segmented into nephrological disorders, neurological disorders, musculoskeletal disorders, gastrointestinal disorders, cardiovascular disorders, and oncology.
View Report @ http://www.transparencymarketresearch.com/global-contrast-media-contrast-agents.html
The global contrast media or contrast agent market has been segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are mature markets for contrast media and contrast agents. Strong infrastructure, improved MRI techniques in cardiovascular diseases, advanced cath-lab and reimbursement policies for contrast media or agent are the factors contributing to the high growth in these regions. Asia Pacific is expected to experience high growth due to increasing number of cardiac and other disorders, and advancement in technology. This region offers manufacturers lucrative opportunities for investment in the market.
Major players in the contrast media or contrast agent market are GE Healthcare, Bracco Imaging S.p.A., Guerbet Group, Bayer HealthCare, CMC Contrast AB, Lantheus Medical Imaging, Daiichi Sankyo, nanoPET Pharma GmbH, and Subhra Pharma Private Limited, among others.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com
0 notes
Text
Diagnostic Imaging Agents Market: Key Players, Trends, Size, Share, Analysis, Estimations And Forecasts To 2025
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.
Get Sample Copy of this Report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309
Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
View Report @ http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com
0 notes
Text
Diagnostic Imaging Agents Market Research Report by Regional Analysis - North America, Europe, Asia Pacific, Latin America, Middle East & Africa : forecast 2025
Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.
Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.
Browse full report on Diagnostic Imaging Agents Market -
http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html
The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.
Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.
The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes